Latest Research

Z Zhang et al, 2021. Genetically Predicted Coffee Consumption and Risk of Alzheimer's Disease and Stroke, Journal of Alzheimer's Disease

X Zhou and L Zhang, 2021. The Neuroprotective Effects of Moderate and Regular Caffeine Consumption in Alzheimer's Disease, Oxid Med Cell Longev, published online.

Y Zhang et al, 2021. Association of coffee and genetic risk with incident dementia in middle-aged and elderly adults, Nutritional Neuroscience, published online.

S K Karuppangounder et al, 2021. Caffeine, a natural methylxanthine nutraceutical, exerts dopaminergic neuroprotection, Neurochem International, published online.

S M Carneiro et al, 2021. Neuroprotective properties of coffee: An update, Trends in Food Science & Technology, Volume

G Leodori et al, 2021. Salivary caffeine in Parkinson's disease, Scientific Reports, Volume 11 (1).

Y Chen et al, 2021. Non-Genetic Risk Factors for Parkinson's Disease: An Overview of 46 Systematic Reviews, Journal of Parkinson’s Disease, published online.

X Ren & J F Chen, 2020. Caffeine and Parkinson’s disease: multiple benefits and emerging pathologies, Frontiers in Neuroscience, published online.

T Filippini et al, 2020. Dietary habits and risk of early-onset dementia in an Italian case-control study, Nutrients, Volume 12 (11)

T Wang et al, 2020. Association between coffee consumption and functional disability in the U.S older adults, British Journal of Nutrition, published online.

This information is intended for Healthcare professional audiences.
Please consider the environment before printing.